secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001493152-24-047842
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INBS fingerprint drug test achieves 94.1% accuracy; FDA submission on track for Q4 2024
--------------------------------------------------------------------------------

- Method comparison study with 135 donors and 9 operators shows 94.1% accuracy, 82.2% sensitivity, 100% specificity for opiate detection.
- FDA 510(k) submission expected in Q4 2024; includes data from PK study and method study.
- System components evaluated: Drug Screening Cartridge, Reader, and Fingerprint Collection Kit.
- CEO Harry Simeonidis states results reaffirm accuracy and reliability for workplace drug testing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224047842/0001493152-24-047842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315224047842/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer